These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 11694816)

  • 41. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
    Dhillon S; Keating GM
    Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J; Qualtrough J; Perrin VL
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A; Hall I; Spelman R
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma.
    Menzies D; Nair A; Hopkinson P; McFarlane L; Lipworth BJ
    Allergy; 2007 Jun; 62(6):661-7. PubMed ID: 17508971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C; Allegra L; Barkai L; Cremonesi G
    Eur Rev Med Pharmacol Sci; 2001; 5(1):17-24. PubMed ID: 11860218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
    Price D; Haughney J; Duerden M; Nicholls C; Moseley C
    Pharmacoeconomics; 2002; 20(10):653-64. PubMed ID: 12162754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
    Barnes NC; Hallett C; Harris TA
    Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J; Cantini L
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
    Lasserson TJ; Cates CJ; Jones AB; Steele EH; White J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005309. PubMed ID: 16235400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
    Ponticiello A; Vatrella A; Parrella R; Romano L; Zofra S; Berlingieri GM; Bariffi F
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C; Guerriero M; Tognella S; Dal Negro RW
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma.
    Petersen R; Agertoft L; Pedersen S
    Eur Respir J; 2004 Dec; 24(6):932-7. PubMed ID: 15572534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.
    Heinig JH; Boulet LP; Croonenborghs L; Möllers MJ
    Respir Med; 1999 Sep; 93(9):613-20. PubMed ID: 10542974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
    Seale JP; Harrison LI
    Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.